386 related articles for article (PubMed ID: 28733974)
1. Impact of diabetes mellitus on procedural and one year clinical outcomes following treatment of severely calcified coronary lesions with the orbital atherectomy system: A subanalysis of the ORBIT II study.
Lee MS; Martinsen BJ; Lee AC; Behrens AN; Shlofmitz RA; Kim CY; Chambers JW
Catheter Cardiovasc Interv; 2018 May; 91(6):1018-1025. PubMed ID: 28733974
[TBL] [Abstract][Full Text] [Related]
2. Impact of age following treatment of severely calcified coronary lesions with the orbital atherectomy system: 3-year follow-up.
Lee MS; Shlofmitz RA; Martinsen BJ; Sethi S; Chambers JW
Cardiovasc Revasc Med; 2018 Sep; 19(6):655-659. PubMed ID: 29452841
[TBL] [Abstract][Full Text] [Related]
3. Orbital atherectomy treatment of severely calcified native coronary lesions in patients with prior coronary artery bypass grafting: Acute and one-year outcomes from the ORBIT II trial.
Lee MS; Anose BM; Martinsen BJ; Lee AC; Shlofmitz RA; Chambers JW
Cardiovasc Revasc Med; 2018 Jul; 19(5 Pt A):498-502. PubMed ID: 29117920
[TBL] [Abstract][Full Text] [Related]
4. Orbital Atherectomy for the Treatment of Long (≥25-40 mm) Severely Calcified Coronary Lesions: ORBIT II Sub-Analysis.
Kumar G; Shin EY; Sachdeva R; Shlofmitz E; Behrens AN; Martinsen BJ; Chambers JW
Cardiovasc Revasc Med; 2020 Feb; 21(2):164-170. PubMed ID: 32014391
[TBL] [Abstract][Full Text] [Related]
5. Orbital atherectomy for treating de novo, severely calcified coronary lesions: 3-year results of the pivotal ORBIT II trial.
Lee M; Généreux P; Shlofmitz R; Phillipson D; Anose BM; Martinsen BJ; Himmelstein SI; Chambers JW
Cardiovasc Revasc Med; 2017 Jun; 18(4):261-264. PubMed ID: 28162989
[TBL] [Abstract][Full Text] [Related]
6. Orbital atherectomy for the treatment of small (2.5mm) severely calcified coronary lesions: ORBIT II sub-analysis.
Lee MS; Shlofmitz RA; Shlofmitz E; Srivastava PK; Kong J; Grines C; Revytak G; Chambers JW
Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):268-272. PubMed ID: 29454531
[TBL] [Abstract][Full Text] [Related]
7. Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
Généreux P; Bettinger N; Redfors B; Lee AC; Kim CY; Lee MS; Shlofmitz RA; Moses JW; Stone GW; Chambers JW
Catheter Cardiovasc Interv; 2016 Sep; 88(3):369-77. PubMed ID: 27084293
[TBL] [Abstract][Full Text] [Related]
8. Procedural and Long-Term Ischemic Outcomes of Tight Subtotal Occlusions Treated with Orbital Atherectomy: An ORBIT II Subanalysis.
Lee MS; Shlofmitz RA; Shlofmitz E; Behrens AN; Revtyak G; Martinsen BJ; Chambers JW
Cardiovasc Revasc Med; 2019 Jul; 20(7):563-568. PubMed ID: 30243964
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of patients with myocardial infarction who underwent orbital atherectomy for severely calcified lesions.
Lee MS; Shlofmitz E; Lluri G; Kong J; Neverova N; Shlofmitz R
Cardiovasc Revasc Med; 2017; 18(7):497-500. PubMed ID: 28529094
[TBL] [Abstract][Full Text] [Related]
10. Acute outcomes after coronary orbital atherectomy at a single center without on-site surgical backup: An experience in diabetics versus non-diabetics.
Whitbeck MG; Dewar J; Behrens AN; Watkins J; Martinsen BJ
Cardiovasc Revasc Med; 2018 Sep; 19(6S):12-15. PubMed ID: 29804796
[TBL] [Abstract][Full Text] [Related]
11. Novel Micro Crown Orbital Atherectomy for Severe Lesion Calcification: Coronary Orbital Atherectomy System Study (COAST).
Redfors B; Sharma SK; Saito S; Kini AS; Lee AC; Moses JW; Ali ZA; Feldman RL; Bhatheja R; Stone GW
Circ Cardiovasc Interv; 2020 Aug; 13(8):e008993. PubMed ID: 32757661
[TBL] [Abstract][Full Text] [Related]
12. Outcomes After Orbital Atherectomy of Severely Calcified Left Main Lesions: Analysis of the ORBIT II Study.
Lee MS; Shlofmitz E; Shlofmitz R; Sahni S; Martinsen B; Chambers J
J Invasive Cardiol; 2016 Sep; 28(9):364-9. PubMed ID: 26984932
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after Atherectomy Treatment of Severely Calcified Coronary Bifurcation Lesions: A Single Center Experience.
Chambers JW; Warner C; Cortez J; Behrens AN; Wrede DT; Martinsen BJ
Cardiovasc Revasc Med; 2019 Jul; 20(7):569-572. PubMed ID: 30201481
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in acute and 30-day outcomes after orbital atherectomy treatment of de novo, severely calcified coronary lesions.
Kim CY; Lee AC; Wiedenbeck TL; Lee MS; Chambers JW
Catheter Cardiovasc Interv; 2016 Mar; 87(4):671-7. PubMed ID: 26331279
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in Diabetic Patients Undergoing Orbital Atherectomy System.
Lee MS; Shlofmitz E; Nguyen H; Shlofmitz RA
J Interv Cardiol; 2016 Oct; 29(5):491-495. PubMed ID: 27489020
[TBL] [Abstract][Full Text] [Related]
16. Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program.
Armstrong EJ; Stanislawski MA; Kokkinidis DG; Plomondon ME; Barón AE; Giri J; Shunk KA; Banerjee S; Maddox TM; Waldo SW
Catheter Cardiovasc Interv; 2018 May; 91(6):1009-1017. PubMed ID: 28766833
[TBL] [Abstract][Full Text] [Related]
17. Direct Stenting in Patients Treated with Orbital Atherectomy: An ORBIT II Subanalysis.
Shlofmitz E; Martinsen BJ; Behrens AN; Ali ZA; Lee MS; Puma JA; Shlofmitz RA; Chambers JW
Cardiovasc Revasc Med; 2019 Jun; 20(6):454-460. PubMed ID: 30982659
[TBL] [Abstract][Full Text] [Related]
18. ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.
Lee MS; Lee AC; Shlofmitz RA; Martinsen BJ; Hargus NJ; Elder MD; Généreux P; Chambers JW
Catheter Cardiovasc Interv; 2017 Apr; 89(5):841-848. PubMed ID: 27567020
[TBL] [Abstract][Full Text] [Related]
19. Orbital atherectomy system in treating calcified coronary lesions: 3-Year follow-up in first human use study (ORBIT I trial).
Bhatt P; Parikh P; Patel A; Chag M; Chandarana A; Parikh R; Parikh K
Cardiovasc Revasc Med; 2014 Jun; 15(4):204-8. PubMed ID: 24746600
[TBL] [Abstract][Full Text] [Related]
20. Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II).
Chambers JW; Feldman RL; Himmelstein SI; Bhatheja R; Villa AE; Strickman NE; Shlofmitz RA; Dulas DD; Arab D; Khanna PK; Lee AC; Ghali MG; Shah RR; Davis TP; Kim CY; Tai Z; Patel KC; Puma JA; Makam P; Bertolet BD; Nseir GY
JACC Cardiovasc Interv; 2014 May; 7(5):510-8. PubMed ID: 24852804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
